Biocon falls even after subsidiary completes biosimilar integration before schedule on December 19, 2023 at 7:10 am

Biocon Biologics acquired all the global biosimilar businesses of Viatris in November 2022.

Leave a comment

Your email address will not be published. Required fields are marked *